Sitemap
June 03, 2017 Articles
Filter by Available Specialty
- Abiraterone acetate with prednisone reduces risk for prostate cancer death
- Addition of abiraterone to androgen deprivation reduces risk for death in advanced prostate cancer
- Baxdela well-tolerated, effective against ABSSSIs
- CancerLinQ partners with FDA, NCI
- Carl H. June, MD, receives ASCO’s highest scientific honor
- DJO Global details financial results for first quarter of 2017
- Enrollment begins for trial of duodenal lining remodeling for type 2 diabetes therapy
- Heart valve disease charity on track to help 1 million underserved people
- High-intensity genomic assay shows promise for early detection of cancer
- Larotrectinib exhibits durable activity in adults, children with various cancers
- Low testosterone levels prevalent among testicular cancer survivors
- New testing method improves treatment of S. aureus at rural community hospital
- Nivolumab shows promise for advanced cervical cancer
- Pembrolizumab plus reduced-dose ipilimumab confers durable antitumor activity in advanced melanoma
- Pregnancy may not affect risk for breast cancer recurrence
- Vaginal bacteria inhibit sexual transmission of HSV-2, possibly Zika
- VIDEO: Portable ophthalmic imaging enhances consult service
- VIDEO: Session on malaria highlights new diagnostic and treatment efforts